GlobeNewswire 07-25 ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartu...
GlobeNewswire 07-23 Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as...
GlobeNewswire 07-22 Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with IXICO ...
GlobeNewswire 07-22 Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association In...
GlobeNewswire 07-21 Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in C...
GlobeNewswire 07-17 Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
GlobeNewswire 07-15 Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer
GlobeNewswire 07-15 Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Bo...
TeleTrader 07-11 US opens lower as trade war continues
GlobeNewswire 07-10 Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investi...
GlobeNewswire 07-01 Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
GlobeNewswire 06-30 Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy
GlobeNewswire 06-27 New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Out...
GlobeNewswire 06-25 Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on P...
GlobeNewswire 06-23 Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
GlobeNewswire 06-18 Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
GlobeNewswire 06-18 TOLREMO therapeutics Announces Strengthening of Leadership: Alessandra Cesano Joins Board of Directo...
GlobeNewswire 06-18 Draig Therapeutics Launches with $140 Million (£107 Million) Total Investment to Advance its Portfol...
GlobeNewswire 06-17 Maxion Therapeutics Appoints Dr. Stefan Härtle as Chief Development Officer
GlobeNewswire 06-16 Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Por...
GlobeNewswire 06-12 Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (E...
GlobeNewswire 06-09 Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive App...
GlobeNewswire 06-09 FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors
GlobeNewswire 06-06 Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
GlobeNewswire 06-05 Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors